Calmodulin activates phosphatidylinositol 3-kinase. 1997

J L Joyal, and D J Burks, and S Pons, and W F Matter, and C J Vlahos, and M F White, and D B Sacks
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.

Calmodulin and phosphatidylinositol 3-kinase are vital components of a number of common intracellular events. Calmodulin, a ubiquitous Ca2+-dependent effector protein, regulates multiple processes in eukaryotic cells, including cytoskeletal organization, vesicular trafficking, and mitogenesis. Phosphatidylinositol 3-kinase participates in events downstream of the receptors for insulin and other growth factors. Here we demonstrate by coimmunoprecipitation and affinity chromatography that Ca2+/calmodulin associates with Src homology 2 domains in the 85-kDa regulatory subunit of phosphatidylinositol 3-kinase, thereby significantly enhancing phosphatidylinositol 3-kinase activity in vitro and in intact cells. Furthermore, CGS9343B, a calmodulin antagonist, inhibited basal and Ca2+-stimulated phosphorylation of phosphatidylinositol in intact cells. These data demonstrate a novel mechanism for modulating phosphatidylinositol 3-kinase and provide a direct link between components of two fundamental signaling pathways.

UI MeSH Term Description Entries
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D002147 Calmodulin A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels. Calcium-Dependent Activator Protein,Calcium-Dependent Regulator,Bovine Activator Protein,Cyclic AMP-Phosphodiesterase Activator,Phosphodiesterase Activating Factor,Phosphodiesterase Activator Protein,Phosphodiesterase Protein Activator,Regulator, Calcium-Dependent,AMP-Phosphodiesterase Activator, Cyclic,Activating Factor, Phosphodiesterase,Activator Protein, Bovine,Activator Protein, Calcium-Dependent,Activator Protein, Phosphodiesterase,Activator, Cyclic AMP-Phosphodiesterase,Activator, Phosphodiesterase Protein,Calcium Dependent Activator Protein,Calcium Dependent Regulator,Cyclic AMP Phosphodiesterase Activator,Factor, Phosphodiesterase Activating,Protein Activator, Phosphodiesterase,Protein, Bovine Activator,Protein, Calcium-Dependent Activator,Protein, Phosphodiesterase Activator,Regulator, Calcium Dependent
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002867 Chromones 1,4-Benzopyrones,Chromone,1,4 Benzopyrones
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000930 Antidiarrheals Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition. Antidiarrheal,Antidiarrheal Agent,Antidiarrheal Drug,Antiperistaltic,Antiperistaltics,Antidiarrheal Agents,Antidiarrheal Drugs,Antiperistaltic Agents,Antiperistaltic Drugs,Agent, Antidiarrheal,Agents, Antidiarrheal,Agents, Antiperistaltic,Drug, Antidiarrheal,Drugs, Antidiarrheal,Drugs, Antiperistaltic
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.

Related Publications

J L Joyal, and D J Burks, and S Pons, and W F Matter, and C J Vlahos, and M F White, and D B Sacks
May 1995, Biochemical Society transactions,
J L Joyal, and D J Burks, and S Pons, and W F Matter, and C J Vlahos, and M F White, and D B Sacks
April 2005, Brain research. Molecular brain research,
J L Joyal, and D J Burks, and S Pons, and W F Matter, and C J Vlahos, and M F White, and D B Sacks
August 2000, Biochemical and biophysical research communications,
J L Joyal, and D J Burks, and S Pons, and W F Matter, and C J Vlahos, and M F White, and D B Sacks
August 2000, Circulation research,
J L Joyal, and D J Burks, and S Pons, and W F Matter, and C J Vlahos, and M F White, and D B Sacks
January 1999, Cellular signalling,
J L Joyal, and D J Burks, and S Pons, and W F Matter, and C J Vlahos, and M F White, and D B Sacks
May 2008, The Journal of biological chemistry,
J L Joyal, and D J Burks, and S Pons, and W F Matter, and C J Vlahos, and M F White, and D B Sacks
August 1994, Oncogene,
J L Joyal, and D J Burks, and S Pons, and W F Matter, and C J Vlahos, and M F White, and D B Sacks
October 1991, Journal of immunology (Baltimore, Md. : 1950),
J L Joyal, and D J Burks, and S Pons, and W F Matter, and C J Vlahos, and M F White, and D B Sacks
August 2000, The Journal of biological chemistry,
J L Joyal, and D J Burks, and S Pons, and W F Matter, and C J Vlahos, and M F White, and D B Sacks
August 1996, The Journal of biological chemistry,
Copied contents to your clipboard!